Latest filing published 21 Jun 2016 for PharMerica CORP.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thomas P. Gerrity: trading record in brief
Thomas P. Gerrity discloses dealings in 7 companies, chiefly Actua Corp, PharMerica Corp and Hercules Inc. Between 3 January 2006 and 17 June 2016, the trades on record add up to 87 filings.
Market trades split into 7 purchases (€288k) and 6 sales (€804k). On balance, insiders were net sellers of €516k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 62 share grants and 4 option exercises.
A typical purchase (the median) is worth €28k.
On 21 June 2016 came the latest disclosure, a share grant in PharMerica Corp. The clock since the last published purchase (23 June 2015) now reads 4,156 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Thomas P. Gerrity
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,167 shares0Common Stock, $0.01 par valueSEC:0001209191-16-129063:0
- 3,730 shares0Common Stock, $0.01 par valueSEC:0001209191-15-055708:0
- 10,000 shares@ US$12.99Common Stock, par value $.001 per shareSEC:0001209191-15-055560:0Canonical exit: 17 Sept 2015 (T+90)
- 6,530 shares0Common Stock, par value $.001 per shareSEC:0001209191-15-053905:0
- 22,500 shares0Common Stock, par value $.001 per shareSEC:0001209191-15-053905:1
- 2,632 shares0Common Stock, par value $.001 per shareSEC:0001209191-15-008947:0
- 1,315 shares@ US$18.24Common Stock, par value .001 per shareSEC:0001209191-15-002226:0
- 1,562 shares@ US$15.36Common Stock, par value $.001 per shareSEC:0001181431-14-033532:0
- 1,054 shares@ US$20.84Common Stock, par value $.001 per shareSEC:0001181431-14-026142:0
- 4,300 shares0Common Stock, $0.01 par valueSEC:0001209191-14-042299:0
- 1,021 shares@ US$21.04Common Stock, par value $.001 per shareSEC:0001181431-14-015467:0
- 7,500 shares0Common Stock, par value $.001 per shareSEC:0001181431-14-002661:0
- 1,169 shares@ US$18.39Common Stock, par value $.001 per shareSEC:0001181431-14-001398:0
- 30,896 shares@ US$17.70Common Stock, par value $.001 per shareSEC:0001181431-13-062601:0
- 15,424 shares@ US$16.31Common Stock, $0.01 par valueSEC:0001209191-13-053873:0
- 12,153 shares@ US$20.70Common Stock, $0.01 par valueSEC:0001209191-13-053873:1
- 3,271 shares@ US$20.56Common Stock, $0.01 par valueSEC:0001209191-13-053873:2
- 1,501 shares@ US$14.32Common Stock, par value $.001 per shareSEC:0001181431-13-052355:0
- 5,556 shares0Common Stock, $0.01 par valueSEC:0001209191-13-035642:0
- 1,884 shares@ US$11.41Common Stock, par value $.001 per shareSEC:0001181431-13-038652:0
- 5,685 shares0Common Stock, $0.01 par valueSEC:0001209191-13-032983:0
- 1,778 shares@ US$12.09Common Stock, par value $.001 per shareSEC:0001181431-13-020670:0
- 7,500 shares0Common Stock, par value $.001 per shareSEC:0001181431-13-014517:0
- 1,837 shares@ US$11.70Common Stock, par value $.001 per shareSEC:0001181431-13-001751:0
- 2,013 shares@ US$10.68Common Stock, par value $.001 per shareSEC:0001181431-12-053412:0
25 of 80 declarations
